| Literature DB >> 30307991 |
Gabriel Motta Pinheiro Brisola1,2, Paulo Eduardo Redkva1,2, Dalton Muller Pessôa Filho3, Marcelo Papoti4, Alessandro Moura Zagatto2,3.
Abstract
The purpose of the present study was to investigate the ergogenic effects of 4 weeks of β-alanine supplementation on peak oxygen uptake ([Formula: see text]) and force associated with [Formula: see text] ([Formula: see text]) during a tethered swimming graded exercise test, and a three-minute all-out effort (3minALL-OUT) in water polo players. Twenty-two male national competitive level water polo players were randomly assigned to receive either 4 weeks of β-alanine (n = 11) or a placebo (n = 11) (i.e., 4.8 g·day-1 for 10 days, then6.4 g·day-1 for 18 days, resulting in 163.2 g over 28 days). The participants performed the TSGET and 3minALL-OUT before and after the supplementation period. There were no significant interaction effects between-groups for any variable, however, the magnitude-based inferences analyses showed a possibly beneficial effect (74%) of β-alanine supplementation on [Formula: see text] compared to placebo treatment (Δ% [post-pre] for Placebo group = -5.2%; Δ% [post-pre] for β-alanine group = +0.7%). Only the β-alanine group presented a significant reduction in [Formula: see text] expressed in absolute values (PRE = 3.3±0.6L·min-1; POST = 3.0±0.4L·min-1; p = .021). Similarly, only the β-alanine group presented a significant increase in critical force (PRE = 51.2±10.4N; POST = 56.5±13.1N; p = .044) and a reduction in the curvature constant parameter (W'; PRE = 2998.0±1103.7N·s; POST = 2224.6±1058.9N·s; p = .049). Thus, we can conclude that 4 weeks of β-alanine supplementation presented mixed results in water polo players, indicating that this nutritional strategy may not be effective in improving parameters of the TSGET and 3minALL-OUT .Entities:
Mesh:
Substances:
Year: 2018 PMID: 30307991 PMCID: PMC6181339 DOI: 10.1371/journal.pone.0205129
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Tethered swimming graded exercise test.
A diagram of the cone positions at the side of the pool used as reference points for the intensities during the tethered swimming graded exercise test (TSGET). Adapted from Papoti et al. [32].
Tethered swimming graded exercise test parameters pre and post supplementation.
| Placebo Group | β-alanine Group | Magnitude-based Inference Analysis (β-alanine Group × Placebo Group) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Pre | Post | Δ% | Pre | Post | Δ% | Effect size (Cohens’s | %Chances (beneficial/ trivial/ harmful) | Qualitative inference | |
| 3.4±0.6 (3.1 to 3.7) | 3.2±0.5 (2.9 to 3.4) | -8.2 | 3.3±0.6 (3.0 to 3.6) | 3.0±0.4 | -9.8 | -0.1±0.6 | 20/40/40 | ||
| 41.7±8.0 (37.5 to 46.4) | 40.1±8.9 (35.4 to 44.9) | -6.9 | 43.4±4.9 (40.4 to 45.9) | 39.9±7.9 (35.8 to 44.6) | -8.0 | 0.0±0.7 | 28/38/34 | ||
| 81.7±15.4 (73.5 to 90.8) | 77.6±10.0 (72.2 to 83.2) | -5.2 | 75.6±12.1 (68.5 to 81.9) | 76.3±18.0 (66.4 to 85.8) | 0.7 | 0.4±0.6 | 74/21/04 | ||
| 429.0±102.3 (367.3 to 486.4) | 424.5±104.6 (360.0 to 482.1) | -1.1 | 413.8±90.9 (362.5 to 462.1) | 424.3±116.0 (358.8 to 492.4) | 3.5 | 0.1±0.5 | 42/46/12 | ||
| 7.7±2.5 (6.4 to 9.1) | 6.6±1.7 (5.7 to 7.5) | -8.2 | 8.5±2.5 (6.6 to 9.5) | 7.3±2.1 (6.2 to 8.5) | -12.4 | 0.1±0.7 | 44/36/20 | ||
Values expressed as Mean±SD (95%CI). = force associated with peak oxygen uptake; TTE = time to exhaustion; = peak oxygen uptake; [La-]peak = peak blood lactate. Δ % = percentage difference (post–pre). The quantitative chances were assessed qualitatively as follows: <1% = most unlikely; 1%–5% = very unlikely; 5%–25% = unlikely; 25%–75% = possibly; 75%–95% = likely; 95%–99% = very likely; and >99% = most likely. If the probabilities of the effect being substantially beneficial and harmful were both > 5%, the effect was reported as unclear.
The magnitude-based inference analysis presents the percentage chance or likelihood that the true effect of the β-alanine supplementation will be beneficial, trivial, or harmful when compared with the placebo condition.
*Significant difference from pre-supplementation (p≤0.05).
The three-minute all-out effort parameters pre and post supplementation.
| Placebo Group | β-alanine Group | Magnitude-based Inference Analysis (β-alanine Group × Placebo Group) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Pre | Post | Δ% | Pre | Post | Δ% | Effect size (Cohens’s | %Chances (beneficial/ trivial/ harmful) | Qualitative inference | |
| 139.8 ±26.6 (126.1 to156.8) | 143.4±23.0 (130.3 to 155.8) | 3.9 | 134.4±17.9 (124.0 to 143.8) | 136.5±20.9 (124.8 to 148.5) | 2.0 | -0.1±0.6 | 23/42/35 | ||
| 70.8±10.7 (65.4 to 77.2) | 72.7±13.2 (66.1 to 80.6) | 2.4 | 67.9±10.3 (62.5 to 73.3) | 68.9±10.6 (62.9 to 74.7) | 1.7 | -0.1±0.3 | 06/68/26 | ||
| 12433.5±3500.2 (10472.4 to 14644.2) | 12706.1±3271.8 (10816.1 to 14462.4) | 8.8 | 11921.5±3009.4 (10141.3 to 13546.3) | 12154.8±3898.1 (9916.8 to 14322.4) | 2.8 | 0.0±0.8 | 34/33/33 | ||
| 71.7±9.7 (66.3 to 77.4) | 67.7±7.4 (63.3 to 71.8) | -4.1 | 71.4±8.9 (66.5 to 76.0) | 72.3±12.1 (65.7 to 79.3) | 1.6 | 0.5±0.8 | 08/19/73 | ||
| 12765.9±1941.2 (11785.2 to 13909.5) | 13087.4±2402.3 (11889.5 to 14516.2) | 2.2 | 12175.1±1859.1 (11180.3 to 13168.2) | 12387.0±1898.4 (11315.4 to 13426.6) | 2.1 | -0.1±0.3 | 09/69/22 | ||
| 56.3±12.3 (49.9 to 63.6) | 59.6±12.0 (53.7 to 66.7) | 7.1 | 51.2±10.4 (45.7 to 57.0) | 56.5±13.1 | 11.2 | 0.2±0.5 | 45/44/11 | ||
| 2891.8±753.0 (2477.6 to 3351.3) | 2359.5±855.8 (1888.3 to 2821.4) | -8.4 | 2998.0±1103.7 (2410.3 to 3606.7) | 2224.6±1058.9 | -17.1 | -0.4±0.9 | 15/23/62 | ||
| 1.2±0.4 (1.0 to 1.4) | 1.2±0.2 (1.1 to 1.3) | 6.6 | 1.2±0.3 (1.0 to 1.3) | 1.3±0.4 (1.1 to 1.5) | 22.1 | 0.4±0.8 | 66/24/10 | ||
| 13.6±2.9 (11.8 to 15.4) | 12.5±3.4 (10.7 to 14.8) | -6.5 | 13.6±3.1 (11.9 to 15.5) | 12.0±2.6 (10.6 to 13.5) | -10.1 | -0.2±0.7 | 16/34/49 | ||
Values expressed as Mean±SD (95%CI). [La-]peak = peak blood lactate; [La-]resting = resting blood lactate; W' = curvature constant parameter. Δ % = percentage difference (post–pre). The quantitative chances were assessed qualitatively as follows: <1% = most unlikely; 1%–5% = very unlikely; 5%–25% = unlikely; 25%–75% = possibly; 75%–95% = likely; 95%–99% = very likely; and >99% = most likely. If the probabilities of the effect being substantially beneficial and harmful were both > 5%, the effect was reported as unclear.
The magnitude-based inference analysis presents the percentage chance or likelihood that the true effect of the β-alanine supplementation will be beneficial, trivial, or harmful when compared with the placebo condition.
*Significant difference from pre-supplementation (p≤0.05).